Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
A Deeper Look At Icahn's Vivus Play
Seeking Alpha
Sun, 09/13/15 - 11:45 am
Carl Icahn
Vivus
This Past Week’s Top 5 Biotech Movers
24/7 Wall St
Sat, 09/12/15 - 01:31 pm
biotech
Akebia Therapeutics
Clovis Oncology
Mirati Therapeutics
Vivus
Vitae
The 3 Most Disappointing Drug Launches of All Time
Motley Fool
Sun, 08/23/15 - 11:49 am
drug launches
MannKind
Afrezza
Sanofi
Zaltrap
Vivus
Arena Pharmaceuticals
Qsymia
Belviq
Can a dwindling rep tally keep Vivus' obesity med in the game?
Fierce Pharma Marketing
Mon, 08/3/15 - 04:52 pm
Vivus
obesity
drug reps
Qsymia
Express Scripts excludes 20 more drugs from 2016 coverage
Yahoo/Reuters
Sat, 08/1/15 - 09:12 am
Express Scripts
formulary
Vivus
Qsymia
AstraZeneca
Onglyza
Lagging Qsymia sales force Vivus to cut sales force again, this time by 50%
Seeking Alpha
Sat, 08/1/15 - 09:01 am
Vivus
Qsymia
layoffs
Vivus reports 2Q loss
Yahoo/AP
Fri, 07/31/15 - 10:59 am
Vivus
earnings
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Seeking Alpha
Mon, 06/22/15 - 12:49 pm
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Apricus Biosciences And Vivus: A Potential Golden Marriage
Seeking Alpha
Wed, 06/17/15 - 10:44 am
Vivus
Apricus Biosciences
M&A
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Vivus's Products Show Greater Coverage From Top U.S. Health Insurance Providers
Seeking Alpha
Thu, 06/4/15 - 12:07 pm
Vivus
Stendra
Qsymia
insurers
Vivus-Qsymia Sales Post Modest Gain - Slow And Steady Does Not Win The Race
Seeking Alpha
Wed, 06/3/15 - 12:34 pm
Vivus
Qsymia
Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate
Seeking Alpha
Tue, 05/26/15 - 09:57 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Belviq
Contrave
Vivus' Stendra To Get A Re-Launch
Seeking Alpha
Tue, 05/12/15 - 04:21 pm
Vivus
Stendra
Endo International
drug launches
erectile dysfunction
Vivus - Qsymia Script Sales Flat Again - Should Vivus Concentrate On Stendra?
Seeking Alpha
Sat, 05/9/15 - 12:19 pm
Vivus
Qsymia
Stendra
obesity
erectile dysfunction
Vivus reports 1st-quarter loss but tops expectations
Yahoo/AP
Tue, 05/5/15 - 05:58 pm
Vivus
earnings
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia
Yahoo
Tue, 04/21/15 - 05:23 pm
Vivus
Qsymia
patents
Analyst: Vivus generic threats a positive for obesity market
Fierce Pharma
Fri, 04/17/15 - 10:35 am
Vivus
obesity
generics
Qsymia
Teva Pharmaceuticals
Actavis
VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents
Yahoo
Thu, 04/16/15 - 09:23 am
Vivus
Teva Pharmaceutical
patents
Qsymia
Vivus to slash obesity salesforce by one-third, turn to digital instead
Fierce Pharma Marketing
Wed, 04/1/15 - 05:33 pm
Vivus
drug reps
layoffs
Qsymia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »